Immucell Value Stock - Dividend - Research Selection
Immucell
ISIN: US4525253062, WKN: 885825
Market price: 6,25 USD
Immucell Fundamental data and company key figures of the share
| Annual reports in USD | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key figures | 29-03-2020 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net operating cash flow | 233.511 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | -1.391.450 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Free cash flow | -1.157.939 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance sheet | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | 28.991.300 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities & Shareholders equity | 38.691.800 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Income statement | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | -1.295.590 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Eps (diluted) | -0,190 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted shares outstanding | 6.818.890 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales/revenue | 13.723.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
| Description | Data |
|---|---|
| Symbol | ICCC |
| Market Capitalization | 42.618.064,00 USD |
| Country | United States |
| Indices | NASDAQ Comp. |
| Sectors | Pharma |
| Raw Data Source | US GAAP in Millionen USD |
| Stock Split | 1990-07-26,1.0000/100.0000; 1990-07-25,1.0000/100.0000; 1990-07-24,1.000000/100.000000 |
| Internet | www.immucell.com |
Description of the company
ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company primarily offers First Defense, an orally delivered scours preventive product for newborn calves. It also provides California Mastitis Test, which is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing purified Nisin treatment for subclinical mastitis in lactating dairy cows; and selling various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to animal health distributors, fleet stores, and direct to farms. The company was founded in 1982 and is headquartered in Portland, Maine.